Rationale and Design of the CREATE Trial: A Multicenter, Randomized Comparison of Continuation or Cessation of Single Antithrombotic Therapy at 1 Year After Transcatheter Aortic Valve Replacement
Background Current guidelines and expert consensus recommend lifelong single antiplatelet therapy for patients undergoing transcatheter aortic valve replacement who have no indication for anticoagulation or dual antiplatelet therapy. However, there is no direct evidence from randomized controlled tr...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2025-04-01
|
| Schriftenreihe: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Schlagworte: | |
| Online-Zugang: | https://www.ahajournals.org/doi/10.1161/JAHA.124.039350 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
